Scroll To Top
News

Patients Stick to Combo Pills

Patients Stick to Combo Pills

Coverx100_546

A study of more than 2,100 HIVers conducted by drugmaker GlaxoSmithKline has found that people taking combination pills had the best rates of adherence to their treatment regimens. The study, published in the November 2005 issue of AIDS Care, showed that HIVers taking Combivir, which combines the medications Epivir and Retrovir into a single pill, were more than twice as likely to achieve a 95% adherence rate than those taking the medications separately.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

Plus Editors

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.